FSMAX | VYMYX | FSMAX / VYMYX | |
Total Expense Ratio | 0.04 | 0.70 | 5% |
Annual Report Gross Expense Ratio | 0.04 | 0.82 | 4% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 11.103 | 3.136 | 354% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 41.4B | 130M | 31,846% |
Annual Yield % from dividends | 0.44 | 0.85 | 51% |
Returns for 1 year | 12.97 | -7.54 | -172% |
Returns for 3 years | 63.92 | 26.67 | 240% |
Returns for 5 years | 49.17 | 31.43 | 156% |
Returns for 10 years | 104.19 | 36.25 | 287% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMOLX | 19.98 | 0.05 | +0.25% |
Lord Abbett Emerging Markets Equity F3 | |||
DLACX | 16.46 | -0.12 | -0.72% |
BNY Mellon Large Cap Equity Y | |||
HAGCX | 53.41 | -0.68 | -1.26% |
Carillon Eagle Mid Cap Growth C | |||
FITIX | 22.27 | -0.30 | -1.33% |
Fidelity Advisor Mid Cap II M | |||
JSJIX | 17.69 | -0.25 | -1.39% |
JHancock Small Cap Dynamic Growth I |